Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.

[1]  H. Sudhoff,et al.  De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. , 2014, European journal of cancer.

[2]  K. Wong,et al.  Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. , 2014, Oral oncology.

[3]  K. Jensen,et al.  Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  A. Garden,et al.  The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer , 2013, Cancer.

[5]  Wei Xu,et al.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Quon,et al.  Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. Ang,et al.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B. Graubard,et al.  Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.

[9]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Primož Strojan,et al.  Retropharyngeal lymph node metastases in head and neck malignancies , 2011, Head & neck.

[11]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[12]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[13]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[14]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Maureen M. O’Brien,et al.  Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus , 2007, The Laryngoscope.

[16]  F. Feng,et al.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. , 2007, International journal of radiation oncology, biology, physics.

[17]  Sandra Nuyts,et al.  Prognostic influence of retropharyngeal lymph node metastasis in squamous cell carcinoma of the oropharynx. , 2006, International journal of radiation oncology, biology, physics.

[18]  R. Hermans,et al.  Retropharyngeal nodes in squamous cell carcinoma of oropharynx: incidence, localization, and implications for target volume. , 2006, International journal of radiation oncology, biology, physics.

[19]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[20]  S. Mukherji,et al.  Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck , 1995, Head & neck.

[21]  H. Harnsberger,et al.  Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part I: normal anatomy. , 1983, Radiology.

[22]  W. G. Maccallum.  PART II. PATHOLOGY , 1918 .

[23]  S. Kubik.  The Anatomy of the Lymphatic System , 1874, Radiologia clinica et biologica.

[24]  Quynh-Thu Le,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Wei Xu,et al.  Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. , 2013, Oral oncology.

[26]  N. Khardori.  Prevalence of Oral HPV Infection in the United States, 2009-2010 , 2012 .